In proton therapy, the design of the system significantly influences key beam parameters, and can have a direct impact on patient care. Thus, it is important to understand beam quality's role in radiotherapy and cancer treatment.​

In the ever-evolving landscape of cancer treatment, how can cancer centers ensure they provide the most advanced proton therapy treatment and highest-quality patient care?

What is the point of view of a medical physicist on the versatility of ProteusONE? In this article, Xuanfeng (Leo) Ding, PhD, the Lead Proton Physicist at Corewell Health’s William Beaumont University Hospital Proton Therapy Center, emphasizes the groundbreaking versatility of the IBA ProteusONE system. In his opinion, the IBA ProteusONE system stands out as the world’s first versatile proton therapy system, used to treat a wide range of cancer sites.  

When considering the best positioning for proton therapy, the debate between supine and upright methods has gained traction in recent years. In this article, you will discover a radiation oncologist’s point of view in this debate, explained by Dr. Arie Dosoretz, radiation oncologist and managing partner for Advocate Radiation Oncology and Southwest Florida Proton in Fort Myers, Florida. 

DynamicARC promises to revolutionize proton therapy by providing faster, sharper and simpler treatments to enhance patient care. In this blog, Dr. Rohan Deraniyagala, Medical Director at William Beaumont Hospital, part of the Corewell Health System, explains the advantages of this innovative technology, highlighting its ability to provide quicker treatments as a primary benefit for cancer patients. Patients undergoing proton therapy with DynamicARC can find themselves on the treatment table for less time, which is a critical factor in their overall experience and comfort.^1,2 The faster treatment may also result in increased efficiency, allowing hospitals to accommodate a higher throughput of patients, making a real difference in cancer care accessibility.³  

DynamicARC* represents a pivotal breakthrough in radiation therapy and in cancer treatment. In this blog, Dr. Craig Stevens, Professor and Chair of the Department of Radiation Oncology at William Beaumont Hospital, part of the Corewell Health System, emphasizes to what extent DynamicARC is key to the future of radiation therapy with protons, enabling a paradigm shift in cancer treatment.  

Find out how ProteusONE at IEO Milan combines precision, patient comfort, and future-ready technology to set new standards in cancer care.

As a hospital executive, head of the radiotherapy department, radiation oncologist, medical physicist or radiotherapist, you may wonder if adding proton therapy treatment to your radiation oncology department can increase your hospital’s attractivity, improve cancer patient experience, and contribute to talent attraction and retention. ​

Prof. Barbara Alicja Jereczek-Fossa is Chair of Radiation Oncology at the European Institute of Oncology (IEO) in Milan and full Professor at the University of Milan, in Italy. She was elected President of the European Society for Radiotherapy and Oncology (ESTRO) in 2024 and her term is set to begin in 2026. ESTRO’s mission is to reinforce radiation oncology as a core partner in multidisciplinary cancer care and to guarantee accessible and high-value radiation therapy for all cancer patients who need it. Prof. Jereczek-Fossa, a highly respected radiation oncologist, brings decades of clinical experience, institutional leadership at the IEO, and a powerful vision for expanding access to precision therapies like proton therapy worldwide. This article highlights her view on proton therapy and the future of precision cancer care.